In the field of genetics, genome-wide association studies (GWAS) have highlighted a strong link between the LPA gene and PAD, indicating that therapeutic modulation of circulating Lp(a) could be effective for the PAD phenotype [137]. The gene discussed is LPA; the disease is peripheral arterial disease.